- Home
- BNZI vs ADXN Comparison
BNZI vs ADXN Comparison
Compare BNZI & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- ADXN
- Stock Information
- Founded
- BNZI 2016
- ADXN 2002
- Country
- BNZI United States
- ADXN Switzerland
- Employees
- BNZI N/A
- ADXN N/A
- Industry
- BNZI
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- BNZI
- ADXN Health Care
- Exchange
- BNZI Nasdaq
- ADXN Nasdaq
- Market Cap
- BNZI 9.5M
- ADXN 8.5M
- IPO Year
- BNZI N/A
- ADXN N/A
- Fundamental
- Price
- BNZI $1.71
- ADXN $7.90
- Analyst Decision
- BNZI Strong Buy
- ADXN Strong Buy
- Analyst Count
- BNZI 1
- ADXN 1
- Target Price
- BNZI $125.00
- ADXN $30.00
- AVG Volume (30 Days)
- BNZI 3.3M
- ADXN 43.4K
- Earning Date
- BNZI 11-14-2024
- ADXN 11-22-2024
- Dividend Yield
- BNZI N/A
- ADXN N/A
- EPS Growth
- BNZI N/A
- ADXN N/A
- EPS
- BNZI N/A
- ADXN 0.06
- Revenue
- BNZI $4,310,782.00
- ADXN $701,260.00
- Revenue This Year
- BNZI $23.28
- ADXN N/A
- Revenue Next Year
- BNZI $66.99
- ADXN N/A
- P/E Ratio
- BNZI N/A
- ADXN $0.91
- Revenue Growth
- BNZI N/A
- ADXN N/A
- 52 Week Low
- BNZI $1.30
- ADXN $5.39
- 52 Week High
- BNZI $194.00
- ADXN $27.90
- Technical
- Relative Strength Index (RSI)
- BNZI 49.12
- ADXN 44.92
- Support Level
- BNZI $1.34
- ADXN $7.62
- Resistance Level
- BNZI $1.81
- ADXN $8.32
- Average True Range (ATR)
- BNZI 0.23
- ADXN 0.57
- MACD
- BNZI 0.07
- ADXN 0.07
- Stochastic Oscillator
- BNZI 29.68
- ADXN 44.76
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling better marketing, sales and customer engagement outcomes. The company sells its products using a recurring subscription license model typical in SaaS businesses. Pricing tiers for its main product, Demio, are based on the number of host-capable users, desired feature sets, and maximum audience size.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.